| Pre- ERAS group (Jun-12 to Aug-13) | ERAS Group (Dec-13 to Nov-14) | p | |
---|---|---|---|---|
Pre-operative non opioid medications usage | Acetaminophen n (%) | 28 (9.4Â %) | 277 (89.4Â %) | <0.001 |
Diclofenac n (%) | 2 (0.7Â %) | 104 (33.5Â %) | <0.001 | |
Gabapentin n (%) | 20 (6.7Â %) | 281 (90.6Â %) | <0.001 | |
Scopolamine n (%) | 2 (0.7Â %) | 68 (21.9Â %) | <0.001 | |
Regional analgesia usage | Epidural used for intraoperative analgesia, n (% | 78 (26.2Â %) | 185 (59.7Â %) | <0.001 |
Epidural used for postoperative analgesia, n (%) | 86 (29Â %) | 210 (68Â %) | <0.001 | |
TAP block given for intraoperative analgesia, n (%) | 9 (3Â %) | 26 (8.4Â %) | 0.005 | |
Adjunctive intraoperative medications | Intraoperative Ketamine Infusion, n (%) | 20 (6.7Â %) | 29 (9.4Â %) | 0.24 |
Intraoperative Dexamethasone, n (%) | 90 (30.2Â %) | 133 (42.9Â %) | 0.0014 | |
Intraoperative Ondansetron, n (%) | 260 (87.2Â %) | 272 (87.7Â %) | 0.9 | |
Chemical DVT prophylaxis | Preoperative DVT prophylaxis with subcutaneous Heparin, n (%) | 100 (34Â %) | 273 (88Â %) | <0.001 |
Preoperative antibiotic | Intravenous antibiotics given before incision, n (%) | 268 (90Â %) | 300 (97Â %) | 0.0008 |
Intraoperative fluids | Median introperative crystalloid, ml (min, 1st Q, 3rd Q, max) | 1350 (0, 800, 2000, 30,000) | 1500 (0, 862.5, 2500, 18,000) | 0.027 |
Median intraoperative colloid, ml (min, 1st Q, 3rd Q, max) | 0 (0, 0, 500, 6000) | 0 (0, 0, 0, 4500) | <0.001 | |
Post-operative non opioid medications scheduled usage | Acetaminophen n (%) | 192 (64.4Â %) | 289 (93.2Â %) | <0.001 |
Diclofenac n (%) | 5 (1.7Â %) | 70 (22.6Â %) | <0.001 | |
Gabapentin n (%) | 23 (7.7Â %) | 254 (81.9Â %) | <0.001 | |
Scopolamine n (%) | 80 (26.8Â %) | 188 (60.6Â %) | <0.001 | |
Adherence to ambulation | Patients Ambulating on POD 0, n (%) | 15 (5.0Â %) | 309 (99.7Â %) | <0.001 |
Patients Ambulating on POD 1, n (%) | 91 (30.5Â %) | 307 (99.0Â %) | <0.001 | |
Patients Ambulating on POD 2, n (%) | 97 (32.6Â %) | 299 (96.5Â %) | <0.001 |